Reduced adiponectin levels, as observed in our clinical obesity group, likely contribute to the persistence of inflammatory signaling cascades such as NF-κB activation, thereby amplifying metabolic disruption. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.